The imaging agreement Catholic Health signed on Long Island runs to roughly $500 million, and the money is the least interesting term in it. What the health system bought is a counterparty. For ten years one vendor supplies the fleet, services it, manages its lifecycle, trains the staff who operate it, places its own scientist inside the cardiology service, and holds the roadmap for the software that will run on all of it. That is a capital decision in form and an outsourcing decision in substance, and the governance a regulated buyer applies was built for the first one.
The alliance covers more than 1,300 pieces of technology across six named hospitals and 36 other sites, with roughly half the equipment additions arriving in the first three years against a payment stream that runs the full decade. The release describes the commercial model as "unitary payments and accelerators," and it names an embedded GE HealthCare cardiovascular scientist working directly with Catholic Health clinicians as one of the things that distinguishes the arrangement from buying machines. Catholic Health's Interim President and Chief Executive Officer Gary Havican called it "an important investment in the future of health care on Long Island," a decade-long commitment signed by someone holding the top job on an interim basis. Fierce Healthcare put the system at $3.7 billion in net revenue and more than 17,000 employees, citing its 2025 annual report. Top-line revenue is the wrong instrument for reading affordability, which turns on operating result rather than scale. The term is the exposure.
The Contract Became a Product
GE HealthCare has been signing agreements of this shape since 2023, none of them drafted for Long Island, and now brands them Care Alliances. The components repeat almost line for line: sole or preferred vendor status across whole modality classes, terms running from seven to twenty years, bundled service and lifecycle management, workforce development, embedded vendor staff, and a contractual roadmap for software and AI. The plainest exclusivity language sits in the ten-year agreement University Hospitals in Cleveland signed in October 2023, which names GE HealthCare the sole provider across nuclear medicine, X-ray, vascular and cardiovascular ultrasound, regional CT, fluoroscopy, surgery and bone densitometry. UC San Diego Health went fourteen years, long enough that the deliverables include subscription programmes rather than a fixed list of machines, Smart Subscription for CT and SIGNA Continuum for MR among them, with vendor field engineers embedded in the health system to service them. In the UK, Nuffield Health's own announcement drops the marketing name and uses the procurement category outright, a twenty-year Managed Equipment Service agreement worth £200 million covering nearly 800 pieces of equipment, under which GE HealthCare takes responsibility for "the ongoing acquisition, installation, maintenance, and staff training."
Two competitors sell the same instrument under different names, and the second one arrived eleven days after the Catholic Health release. Siemens Healthineers calls its version a Value Partnership, and Vanderbilt Health announced an $87 million dollar multi-year agreement on 27 July making Siemens the primary technology provider for MRI, CT, molecular imaging, interventional radiology and Varian radiation oncology across its Middle Tennessee hospitals. Philips runs a preferred-vendor lifecycle alliance of its own, most recently a seven-year arrangement with WellSpan Health spanning twelve hospitals. Three vendors, one contractual form, and a customer list that is filling up faster than anyone has published a framework for evaluating it.
The Annuity on the Seller's Side
GE HealthCare describes what it is selling more plainly to investors than to buyers. On the company's fourth-quarter call in February, President and Chief Executive Officer Peter Arduini said the company had "accelerated growth with more than $7 billion in enterprise deals globally since our spin," and that "many of these deals have a service component that delivers strong, recurring revenue with attractive margins." An analyst asked Chief Financial Officer Jay Saccaro on the same call what the shift away from lumpier capital sales looks like as a share of revenue. Saccaro answered that the company had "talked extensively about our goal to expand recurring revenue," and that expanding enterprise agreements typically carries meaningful multiyear service elements along with it. Six months later the company reported a record $23.9 billion dollar backlog and organic order growth of 11.1% on its second-quarter call, the highest growth rate since it separated from GE. Arduini told analysts on that call that the Catholic Health agreement will "result in orders over time," and that "only about a fifth of those orders are actually a part of what went in the second quarter." The buyer's stated benefit is capital discipline and the seller's is an annuity with a decade of visibility on it, both are true at once, and only one of them gets reported every quarter to an audience that prices it.
What the Long Term Does to Oversight
The payment mechanism has a longer history than the product name. A unitary charge, paid on a schedule across a long term to a counterparty that owns and maintains the asset, is the payment form of the UK's private finance initiative, and Britain has already audited what a horizon like that does to the buyer's position. The National Audit Office's 2020 review of PFI contracts approaching expiry found that 35% of the authorities monitoring a maintenance programme said they had insufficient access rights to do it adequately, and that around 55% recognised they needed more knowledge of the condition of assets they were shortly going to take back. Those are drafting failures rather than operator failures, and they compound without surfacing, because nothing forces the question until the hand-back.
The vendors are not hiding the trade, and Philips makes the as-a-service case directly to hospital finance chiefs while conceding the objection in the same document, allowing that total cost of ownership "might appear to be more than that of capital purchase with financing and maintenance services" and describing a band of 80% to 120% variability written in to share risk between the parties. What the public record does not contain is a failure. Searching for a long single-vendor health-system alliance that was unwound early, blew out on cost, or drew audit or antitrust scrutiny turns up nothing, and that's a null result rather than a finding. The oldest of these agreements is not yet three years old. Nobody has run one to term, so there is no hand-back to learn from and no dispute to read.
Finance Wrote These Rules Already
Financial services worked through the same question a decade earlier and turned the answer into supervision. The Financial Conduct Authority, the Prudential Regulation Authority and the Bank of England published the critical third parties regime in November 2024, in force from the first of January 2025. The Financial Stability Board's 2023 toolkit for third-party risk management carries dedicated sections on exit strategies and on concentration. The FCA's note on the lessons of the CrowdStrike outage records that "between 2022 and 2023, third-party related issues were the leading cause of operational incidents reported to us." None of that tells a bank who it may buy from. It expects the bank to know what it would do if the supplier stopped, and to hold a stated view on how much of itself sits with any single one of them.
Healthcare has no equivalent, and the sharpest analysis of vendor concentration in the sector was written for the benefit of finance. The Office of Financial Research, a Treasury body, published a brief on the Change Healthcare cyberattack as a lesson in financial stability, recording that the platform touches "one of every three patient records" and handles "$2 trillion in annual medical claims," that about 189,000 medical providers use it, that an American Hospital Association survey found 94% of hospitals financially affected, and that first-quarter 2024 hospital revenue came in 16.5% to 17.9% under projection according to Strata Decision Technology. Peer-reviewed work points the same way. A Health Affairs Scholar paper on electronic health record consolidation, citing prior research for the market shares, records that two vendors now cover 71.7% of the inpatient and 69% of the ambulatory electronic health record market, that "EHR switching costs are extremely high for health systems," and that a database-engineering mistake at Oracle Health in April 2025 produced a five-day outage at 45 of Community Health Systems' 71 hospitals. Its authors conclude that the remedy has to be oversight rather than antitrust, precisely because the switching costs make the structure effectively permanent.
The AI commitment buried in a ten-year contract has a regulatory mechanism most buyers have never read. The FDA finalised guidance in December 2024 allowing a manufacturer to pre-authorise future modifications to an AI-enabled device software function through a Predetermined Change Control Plan, so a cleared algorithm can be changed against a protocol agreed in advance without a new marketing submission. That is a sensible answer to a real problem, and it moves the decision about what the software does next out of the regulator's hands and into the commercial relationship. A system that has signed for a decade of AI roadmap has agreed to updates nobody can describe yet. Whether it can review them, refuse them, or walk, depends entirely on what its own lawyers wrote in year one.
Most of the work that pays here happens before signature and needs no market to standardise first. Price the exit at year seven, while the vendor still wants the deal and will quote a number. Write access and information rights that outlive the people who negotiated them, since the NAO's finding is that those rights are the first thing a long contract forgets to include. Set a figure for how much of the estate any one counterparty may hold, and make the next alliance clear it. Healthcare is signing single-counterparty commitments on infrastructure timescales against governance designed for buying equipment, and the sector that already learned this lesson wrote its rules down.
